Theranostics

Specialties

Theranostics

Cancer is personal. Its treatment should be too. GE Healthcare’s complete portfolio of Theranostics-enabling solutions is designed specifically for this new era in cancer care. Join us on this journey to transform the approach to cancer discovery, diagnosis, and treatment. Because the future of medicine is here—and it’s personal. Are you ready?

Choose a topic

Total MI for Theranostics: The power to Discover. Diagnose. Treat.

GE Healthcare is pioneering the Theranostics pathway, always seeing the potential for new advancements. Join us as we pioneer the solutions that bring hope.

Get started

The future of healthcare is Theranostics

We are miraculously diverse. Singular in biology. Unique in variance. United in hope … for a better tomorrow.

Theranostics - Video Teaser

DIGITAL AI INNOVATIONS

Integrating digital products and solutions across the care pathways

With precision care, you need to simplify your workflow, including quantitation and dosimetry processes, empower your quantitation with AI, and efficiently and accurately complete organ segmentation. GE is meeting those needs with integrated solutions that help simplify clinical and research workflows.

mCRPC patient; ¹⁸F-DCFPyL, Discovery MI 20 cm (L); ¹⁷⁷Lu-PSMA-617, StarGuide post therapy (R)

Courtesy of Prof lagaru, Stanford Univ.

Imaging on same day of treatment; ¹⁷⁷Lu Dotatate, NM/CT 870 CZT

Courtesy of Barnes-Jewish Hospital

¹⁸F-PSMA, Discovery MI Gen 2 30 cm

Courtesy of Zurich University Hospital

Advanced Metastatic Prostate Cancer; ¹⁷⁷Lu-PSMA, NM/CT D670 CZT before and after treatment

Courtesy of Rambam Health Care Center

¹⁸F-PSMA, Omni Legend after prostate removal

Courtesy of Rambam Health Care Center

¹⁷⁷Lu Octreotate StarGuide, post therapy for metastatic neuroendocrine tumors

Courtesy of Prof lagaru, Stanford Univ.

Xeleris™ V Theranostics Package

Eliminate the need for a standalone nuclear medicine workstation with this virtual processing and review solution featuring cutting-edge applications to be used in the Theranostics pathway – powered by AI – to give you greater flexibility and enhanced workflow.

Practical considerations needed in establishing a Theranostics program from SNMMI 2022: We really have a long way to go to meet the need of the market right now let alone what is coming in the future.

THOUGHT LEADERSHIP

Here's what today’s medical leaders are saying

INNOVATIONS

Only GE Healthcare —for wherever you are on your Theranostics journey

The future is happening now. One-size-fits-all just doesn’t work anymore. At GE Healthcare, we’re personalizing the path to precision healthcare. Join us, as we work toward enabling better outcomes. Join us, as we provide hope.

Researchers and Academic Centers

By partnering with GE Healthcare—the only vendor with a complete Theranostics package—you get ground-breaking technology and the exceptional MI solutions. And, you get the promise of continued research, keeping you at the forefront of your industry.

Community Hospitals and Imaging Centers

You can see the future of molecular imaging—bringing hope to your cancer patients. With GE Healthcare as your partner, you will protect your investments, distinguish your facility from others—and keep your patients close to home.

Referring Physicians

Extending lives and relieving pain is everything. GE Healthcare’s comprehensive approach to Theranostics is the key to disease management. Our approach is part of the future of cancer evaluation and monitoring. And the future is happening now.

Patients

We’re with you on your cancer care journey. We know every step is critical. Every step is hard. That’s why with GE Healthcare you get precise, personal solutions. It’s the future of cancer treatment. And it’s happening now.

Omni Legend 32cm as compared to Discovery MI 25cm. Measurements follow NEMA NU 2-2018.
Omni Legend compared to Discovery MI. As demonstrated in phantom testing.
Source: MEDRaysintell2021
Omni Legend compared to Discovery MI. As demonstrated in phantom testing.
Q.Thera AI is 510(k) pending at the US FDA. Not cleared for sales in the United States.
Compared to using Xeleris’s Dosimetry Toolkit with dose calculations done with external software. As demonstrated in bench test using 5 SPECT-CT cases. The bench test covered the workflowfrom data loading to image processing and dose calculation. Results may vary.
Compared to using Xeleris 4 DR Q.Volumetrix MI with manual or external software dose calculation. As demonstrated in an evaluation at 2 sites consisting of 15 SPECT-CT cases and 2 physicians, where each case was processed by 1 of the 2 physicians. Results may vary.
Compared to using Xeleris 4 DR Q.Volumetrix with manual or external software dose calculation. As demonstrated in bench test using 5 SPECT-CT cases. The bench test covered the workflow from data loading to dose calculation using user pre-defined formulas. Results may vary.
https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html#:~:text=Other%20than%20skin%20cancer%2C%20prostate,34%2C500%20deaths%20from%20prostate%20cancer

Have a question? We would love to hear from you.

We're sorry, a problem occurred with the form. Please try again.

Thank you!

We received your request for assistance.

A GE Healthcare specialist will be reaching out shortly.

Something went wrong

We will check and get back.

Try Again

JB07723US November 2022

Choose a topic

Total MI for Theranostics: The power to Discover. Diagnose. Treat.

GE Healthcare is pioneering the Theranostics pathway, always seeing the potential for new advancements. Join us as we pioneer the solutions that bring hope.

1

Question {0} of {1}

What's your specialty?

2

Question {0} of {1}

Insights and Products

No results found

and

You selected {0} as your job role and {1} as your specialty.

Results for your job role

Results for your specialty

Integrating digital products and solutions across the care pathways

Only GE Healthcare —for wherever you are on your Theranostics journey

Researchers and Academic Centers

Community Hospitals and Imaging Centers

Referring Physicians

Patients

Have a question? We would love to hear from you.

Choose a topic

Total MI for Theranostics: The power to Discover. Diagnose. Treat.

GE Healthcare is pioneering the Theranostics pathway, always seeing the potential for new advancements. Join us as we pioneer the solutions that bring hope.

1

Question {0} of {1}

What's your specialty?

2

Question {0} of {1}

Insights and Products

No results found

and

You selected {0} as your job role and {1} as your specialty.

Results for your job role

Results for your specialty

GE Healthcare’s PET Radiopharmacy drives innovation

GE is pioneering the solutions that enable unparalleled sensitivity and diagnostic confidence.

Cancer is personal. Its treatment should be too.

Digital Accuracy for Precision Health

Integrating digital products and solutions across the care pathways

Only GE Healthcare —for wherever you are on your Theranostics journey

Researchers and Academic Centers

Community Hospitals and Imaging Centers

Referring Physicians

Patients

Have a question? We would love to hear from you.

Cancer is personal.
Its treatment should be too.